Mylan gets FDA approval for HIV treatment Ruby Khatun Khatun1 April 2018 10:15 AM ISTGlobal pharmaceutical company Mylan N.V. announced that it will introduce in the U.S. a third cost-saving HIV combination.The U.S. Food and Drug...
Indian antibiotics usage witnessed 103 percent rise in 15 years: Study Ruby Khatun Khatun1 April 2018 10:00 AM ISTIndia witnessed the highest increase in antibiotic consumption among Low and Middle-Income Countries (LMICs) between 2000 and 2015, a study has...
FDA expands use of Amgen leukemia drug Blincyto to patients with relapse risk Ruby Khatun Khatun1 April 2018 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the use of Amgen Inc’s leukemia drug Blincyto to include patients who are in remission but still...
Lupin gets USFDA approval for generic psoriasis drug Ruby Khatun Khatun31 March 2018 10:30 AM ISTNew Delhi: Drug major Lupin said it has received USFDA's approval to market Clobetasol Propionate spray, used for treating plaque psoriasis, in the...
Huge consignment of fake, prohibited medicines seized in Amroha, four held Ruby Khatun Khatun31 March 2018 10:15 AM ISTAmroha: Local police and drugs department in a joint operation seized huge consignment of fake and prohibited medicines in Hasanpur area.Assistant...
Dr Reddy’s Laboratories appoints Erez Israeli as COO Ruby Khatun Khatun31 March 2018 10:00 AM ISTHyderabad: Dr Reddy’s Laboratories Ltd announced the appointment of Erez Israeli, former president and CEO of Enzymotec, as the chief operating...
Pfizer's rare heart disease drug succeeds in late-stage study Ruby Khatun Khatun31 March 2018 9:30 AM ISTPfizer Inc’s experimental drug to treat a rare and fatal disease linked to heart failure reduced deaths and need for hospitalizations in a late-stage...
Licence renewal of drug firms: CAG slams FDA Ruby Khatun Khatun30 March 2018 4:58 PM ISTMumbai: The country's apex auditor CAG has slammed the Food and Drug Administration (FDA), an agency of the Maharashtra government, over the shortage...
Biocon, Mylan get European Commission approval to market biosimilar insulin glargine Ruby Khatun Khatun30 March 2018 10:30 AM ISTNew Delhi: Biotechnology major Biocon and Mylan said their co-developed biosimilar insulin glargine has received marketing authorization approval from...
Investigation going on priority basis in Fortis, Religare matter: Sebi Ruby Khatun Khatun30 March 2018 10:05 AM ISTMumbai: Markets regulator Sebi said the investigation is going on a priority basis into the matter related to alleged lapses at Fortis Healthcare and...
FDA working on a dozen policies to boost copycat biotech drugs Ruby Khatun Khatun30 March 2018 9:45 AM ISTNEW YORK: The U.S. Food and Drug Administration is working on around a dozen actions to boost use of cheaper versions of expensive biotech medicines,...
Roche shares drop after deaths of patients taking Hemlibra Ruby Khatun Khatun30 March 2018 9:30 AM ISTZURICH: Swiss drugmaker Roche’s shares dropped after it told U.S.-based haemophilia advocacy groups that five patients treated with its medicine...
